<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01169311</url>
  </required_header>
  <id_info>
    <org_study_id>COVHEPH0021</org_study_id>
    <nct_id>NCT01169311</nct_id>
  </id_info>
  <brief_title>Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure</brief_title>
  <official_title>A Prospective, Multi-Center Investigation Of The Safety And Performance Of The Covidien EEA™ Hemorrhoid And Prolapse Stapling Set With DST Series™ Technology Im A Hemorrhoidopexy Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial Objectives

      The primary objectives of this clinical trial are to estimate the Covidien EEA™ Hemorrhoid
      and Prolapse Stapling Set:

      overall performance defined by the successful creation of a normal staple line safety as
      measured by the 30 day incidence of adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uneventful Creation of a Functional Staple Line at First Firing of Device</measure>
    <time_frame>about 20 minutes for procedure</time_frame>
    <description>Successful creation of staple line at first firing of device during hemorrhoidopexy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>OR Time</measure>
    <time_frame>Day 0 - Time of stop minus time of start</time_frame>
    <description>Duration of procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-Operative Bleeding Requiring Intervention</measure>
    <time_frame>Day 0 - time of surgery</time_frame>
    <description>Incidence of intervention for intra-operative staple-line bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Day 0, time of discharge minus time of admission</time_frame>
    <description>length of time between time of admission and time of discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Return to Normal Activity</measure>
    <time_frame>30 days post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Stapler Malfunction or Misfires</measure>
    <time_frame>about 20 minutes for procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Pain</measure>
    <time_frame>baseline, 30 days post op</time_frame>
    <description>Post operative pain measured by 11 point visual analog scale, measured as change from baseline The scale range is 0-10, where 0 = no pain and 10 = worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life, Physical Component</measure>
    <time_frame>baseline, 30 days post op</time_frame>
    <description>Physical component score SF36 scale measured as change from baseline the scoring ranges from 0 to 100 with 0 = unable to do anything while 100 = capable of physical activity without limitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life, Mental Component</measure>
    <time_frame>Baseline, 30 days post op</time_frame>
    <description>quality of life, SF36 measure as change from baseline the scoring ranges from 0 to 100 with 0 = complete mental activity limitation; while 100 = capable of mental activity without limitation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Hemorrhoid</condition>
  <arm_group>
    <arm_group_label>HEEA Stapler</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hemorrhoidopexy using Covidien EEA Hemorrhoid and Prolapse Stapling Set</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemorrhoidopexy</intervention_name>
    <arm_group_label>HEEA Stapler</arm_group_label>
    <other_name>Covidien EEA Hemorrhoid and Prolapse Stapling set</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to understand and sign Informed Consent Form

          -  The participant must be 18-80 years of age.

          -  The participant has (symptomatic) Grade 2-4 Hemorrhoids and is eligible for stapled
             hemorrhoidopexy.

        Exclusion Criteria:

          -  The procedure is needed as revision hemorrhoid surgery.

          -  The participant is pregnant.

          -  The participant has an active or a history of infection requiring antibiotics at the
             intended operative site within thirty (30) days prior to the planned surgery date.

          -  The participant is unable or unwilling to comply with the study requirements,
             follow-up schedule.

          -  The participant has a history of drug or alcohol abuse.

          -  The participant has a history of venous thrombosis or pulmonary embolism.

          -  The participant has a history of coagulopathy.

          -  The participant is taking aspirin, anti-coagulation and/or anti platelet therapies
             (e.g.: Warfarin, Levonox) within the last 7 days prior to the planned surgery date

          -  The participant has a history of fecal incontinence.

          -  The participant has co-morbidities which, in the opinion of the investigator, will not
             be appropriate for the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Lee, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2010</study_first_submitted>
  <study_first_submitted_qc>July 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2010</study_first_posted>
  <results_first_submitted>January 17, 2014</results_first_submitted>
  <results_first_submitted_qc>September 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 6, 2014</results_first_posted>
  <last_update_submitted>September 30, 2014</last_update_submitted>
  <last_update_submitted_qc>September 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemorrhoids</keyword>
  <keyword>Hemorrhoid</keyword>
  <keyword>grade II, III, IV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between 21 July 2010 and 17 March 2011 patients were recruited at 2 medical clinic and one hospital; subjects with grades 2-4 hemorrhoids eligible for stapled hemorroidopexy were assessed for eligibility for study; exclusion criteria: pregnant,Ab use for SSI, drug/alcohol abuse, aspirin/anticuagulant therapy, hx VT, hx PE,</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
          <description>Subjects meeting inclusion/exclusion criteria will undergo hemorrhoidopexy with the Covidien EEA hemorrhoid and prolapse stapler set.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
          <description>Subjects undergoing hemorrhoidopexy with HEEA stapler</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.2" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Uneventful Creation of a Functional Staple Line at First Firing of Device</title>
        <description>Successful creation of staple line at first firing of device during hemorrhoidopexy</description>
        <time_frame>about 20 minutes for procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Uneventful Creation of a Functional Staple Line at First Firing of Device</title>
          <description>Successful creation of staple line at first firing of device during hemorrhoidopexy</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>OR Time</title>
        <description>Duration of procedure</description>
        <time_frame>Day 0 - Time of stop minus time of start</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>OR Time</title>
          <description>Duration of procedure</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.5" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intra-Operative Bleeding Requiring Intervention</title>
        <description>Incidence of intervention for intra-operative staple-line bleeding</description>
        <time_frame>Day 0 - time of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Intra-Operative Bleeding Requiring Intervention</title>
          <description>Incidence of intervention for intra-operative staple-line bleeding</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay</title>
        <description>length of time between time of admission and time of discharge</description>
        <time_frame>Day 0, time of discharge minus time of admission</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>length of time between time of admission and time of discharge</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146.6" spread="167.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Return to Normal Activity</title>
        <time_frame>30 days post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Return to Normal Activity</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Stapler Malfunction or Misfires</title>
        <time_frame>about 20 minutes for procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>Subjects meeting inclusion/exclusion criteria will undergo hemorrhoidopexy with the Covidien EEA hemorrhoid and prolapse stapler set.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Stapler Malfunction or Misfires</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Operative Pain</title>
        <description>Post operative pain measured by 11 point visual analog scale, measured as change from baseline The scale range is 0-10, where 0 = no pain and 10 = worst possible pain</description>
        <time_frame>baseline, 30 days post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Post Operative Pain</title>
          <description>Post operative pain measured by 11 point visual analog scale, measured as change from baseline The scale range is 0-10, where 0 = no pain and 10 = worst possible pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life, Physical Component</title>
        <description>Physical component score SF36 scale measured as change from baseline the scoring ranges from 0 to 100 with 0 = unable to do anything while 100 = capable of physical activity without limitation</description>
        <time_frame>baseline, 30 days post op</time_frame>
        <population>Only subjects who completed the SF-36 questionnaire were included in the analysis. The number of participants reflects 24/27 subjects completed the questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life, Physical Component</title>
          <description>Physical component score SF36 scale measured as change from baseline the scoring ranges from 0 to 100 with 0 = unable to do anything while 100 = capable of physical activity without limitation</description>
          <population>Only subjects who completed the SF-36 questionnaire were included in the analysis. The number of participants reflects 24/27 subjects completed the questionnaire.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.95" spread="8.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 days post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.61" spread="8.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life, Mental Component</title>
        <description>quality of life, SF36 measure as change from baseline the scoring ranges from 0 to 100 with 0 = complete mental activity limitation; while 100 = capable of mental activity without limitation</description>
        <time_frame>Baseline, 30 days post op</time_frame>
        <population>Only subjects who completed the SF-36 questionnaire were included in the analysis. The number of participants reflects 24/27 subjects completed the questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
            <description>subjects will have have hemorrhoidopexy using the EEA stapler</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life, Mental Component</title>
          <description>quality of life, SF36 measure as change from baseline the scoring ranges from 0 to 100 with 0 = complete mental activity limitation; while 100 = capable of mental activity without limitation</description>
          <population>Only subjects who completed the SF-36 questionnaire were included in the analysis. The number of participants reflects 24/27 subjects completed the questionnaire.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.12" spread="5.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 Days post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="3.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were colllected from time of enrollment (Day 0, time of surgery) until subject's final visit at one month +/- 1 week post surgery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Covidien EEA Hemorrhoid and Prolapse Stapler</title>
          <description>Subjects undergoing hemorrhoidopexy with HEEA stapler</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anorectal Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Rectal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>vomitting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Local Swelling</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Post procedural hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tam LaFleur</name_or_title>
      <organization>Covidien</organization>
      <phone>203-821-4744</phone>
      <email>tam.lafleur@covidien.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

